- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 7/56 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Patent holdings for IPC class C07K 7/56
Total number of patents in this class: 493
10-year publication summary
31
|
40
|
39
|
45
|
40
|
38
|
42
|
26
|
32
|
5
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 5080 |
41 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
36 |
Palatin Technologies, Inc. | 79 |
14 |
Aileron Therapeutics, Inc. | 85 |
11 |
Protagonist Therapeutics, Inc. | 124 |
10 |
President and Fellows of Harvard College | 5792 |
8 |
DSM Sinochem Pharmaceuticals Netherlands B.V. | 62 |
8 |
Polyphor Ltd. | 23 |
8 |
NovoBiotic Pharmaceuticals, LLC | 20 |
7 |
Xellia Pharmaceuticals ApS | 114 |
7 |
Zealand Pharma A/S | 211 |
7 |
Novartis AG | 11238 |
6 |
Provincial Health Services Authority | 155 |
6 |
The University of Tokyo | 3903 |
6 |
Bicyclerd Limited | 130 |
6 |
Wisconsin Alumni Research Foundation | 3774 |
5 |
Universitaet Zuerich | 33 |
5 |
Shanghai Shengdi Pharmaceutical Co., Ltd | 84 |
5 |
Shanghai Senhui Medicine Co., Ltd. | 45 |
5 |
University of South Florida | 1817 |
4 |
Other owners | 288 |